339 related articles for article (PubMed ID: 29407984)
1. Ciprofloxacin derivatives and their antibacterial activities.
Zhang GF; Liu X; Zhang S; Pan B; Liu ML
Eur J Med Chem; 2018 Feb; 146():599-612. PubMed ID: 29407984
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
4. Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2015 Jun; 97():94-103. PubMed ID: 25951434
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
6. Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Molecules; 2015 Apr; 20(4):6254-72. PubMed ID: 25859782
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
Kant R; Singh V; Nath G; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391
[TBL] [Abstract][Full Text] [Related]
8. Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
Shavit M; Pokrovskaya V; Belakhov V; Baasov T
Bioorg Med Chem; 2017 Jun; 25(11):2917-2925. PubMed ID: 28343755
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent ciprofloxacin derivatives.
Alsughayer A; Elassar AA; Hasan AA; Al Sagheer F
Bioorg Chem; 2021 Mar; 108():104658. PubMed ID: 33517003
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.
Purkayastha N; Capone S; Beck AK; Seebach D; Leeds J; Thompson K; Moser HE
Chem Biodivers; 2015 Feb; 12(2):179-93. PubMed ID: 25676502
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
[TBL] [Abstract][Full Text] [Related]
12. 4-Quinolone derivatives and their activities against Gram positive pathogens.
Zhang GF; Zhang S; Pan B; Liu X; Feng LS
Eur J Med Chem; 2018 Jan; 143():710-723. PubMed ID: 29220792
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
[TBL] [Abstract][Full Text] [Related]
14. DNA-interaction and in vitro antimicrobial studies of some mixed-ligand complexes of cobalt(II) with fluoroquinolone antibacterial agent ciprofloxacin and some neutral bidentate ligands.
Patel MN; Chhasatia MR; Gandhi DS
Bioorg Med Chem Lett; 2009 May; 19(10):2870-3. PubMed ID: 19359174
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
[TBL] [Abstract][Full Text] [Related]
16. Organometallic ciprofloxacin conjugates with dual action: synthesis, characterization, and antimicrobial and cytotoxicity studies.
Szczupak Ł; Kowalczyk A; Trzybiński D; Woźniak K; Mendoza G; Arruebo M; Steverding D; Stączek P; Kowalski K
Dalton Trans; 2020 Feb; 49(5):1403-1415. PubMed ID: 31851200
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of ciprofloxacin within modified xanthan gum- chitosan based hydrogel for drug delivery.
Hanna DH; Saad GR
Bioorg Chem; 2019 Mar; 84():115-124. PubMed ID: 30500521
[TBL] [Abstract][Full Text] [Related]
18. Coumarin-containing hybrids and their antibacterial activities.
Feng D; Zhang A; Yang Y; Yang P
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900380. PubMed ID: 32253782
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.
Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J
Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259
[TBL] [Abstract][Full Text] [Related]
20. Novel cajaninstilbene acid derivatives as antibacterial agents.
Geng ZZ; Zhang JJ; Lin J; Huang MY; An LK; Zhang HB; Sun PH; Ye WC; Chen WM
Eur J Med Chem; 2015 Jul; 100():235-45. PubMed ID: 26093280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
